หนังสือแสดงการรับทราบความผิด 28 February 2018 Subject : Management Discussion and Analysis of the year ended 31 December 2017 Attn. : Director and Manager The Stock Exchange of Thailand Encls. : A
Ref. PDI/BK-BS-036/2019 10th May 2019 Re: Management Discussion and Analysis (MD&A) For the three-month period ended March 31, 2019 To: President The Stock Exchange of Thailand PDI reassessed its
หนังสือแสดงการรับทราบความผิด 13 May 2019 Subject : Management Discussion and Analysis of the first quarter 2019 ended 31 March 2019 Attn. : Director and Manager The Stock Exchange of Thailand Encls
1 NO. NCH 024/2562 July 11, 2019 Subject : Notice of setting up a new subsidiary under joint venture agreement to cover intermediate care and wellness business Attn. : Director and Manager The Stock
Microsoft Word - MD&A_Q2_2019_EN 14.8.19 1 NPPG.050/2562 August 14th, 2019 Subject Management’s analysis for the 2nd quarter of 2019 Attn. The President The Stock Exchange of Thailand Management’s
19 September 2005 - Translate – Ref. HF 0109/2018 August 6th, 2018. Subject : Disclosure of Connected Transaction. Attn : Managing Director of the Stock Exchange of Thailand. According to the
No. : 0107535000371 No. L039/2018 7th August 2018 Subject : The explanation of operating results for the 2nd quarter 2018 Attention : The President The Stock Exchange of Thailand Dear Sir, For the
19 September 2005 - Translate – Ref. HF 0109/2018 August 6th, 2018. Subject : Disclosure of Connected Transaction (Additional) Attn : Managing Director of the Stock Exchange of Thailand. According to
/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
-1- November 29, 2018 Subject Change of payment method for investment in acquisition and sale of tap water in some areas of Phuket and some areas of Phangnga. To Director and Manager The Stock